Antiphospholipid syndrome

Publication date: Available online 19 December 2019Source: Best Practice &Research Clinical RheumatologyAuthor(s): Lisa R. SammaritanoAbstractAntiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or pregnancy morbidity in the setting of documented persistent antiphospholipid antibodies that include the lupus anticoagulant, or moderate-high titer anticardiolipin, or anti-β2Glycoprotein I antibodies. Associated clinical manifestations include livedo reticularis, cutaneous ulcerations, thrombocytopenia, hemolytic anemia, valvular heart disease, and nephropathy. The degree of risk associated with antiphospholipid antibody depends on the characteristics of the antiphospholipid antibody profile and on the presence of additional thrombotic risk factors. Current standard treatment for unprovoked thrombosis is long-term warfarin or other vitamin K antagonist therapy. Treatment to prevent recurrent obstetric complications is low-dose aspirin and prophylactic heparin, usually low-molecular-weight heparin. Optimal treatment for standard therapy failures or for certain nonthrombotic manifestations is uncertain, although nonanticoagulation therapies that address multiple demonstrated mechanisms of disease are being explored.
Source: Best Practice and Research Clinical Rheumatology - Category: Rheumatology Source Type: research

Related Links:

Authors: Brima N, Samba TT, Yamba A, Barrett G, Stephenson J, Hall J Abstract New ways of measuring pregnancy planning/intention such as the London Measure of Unplanned Pregnancy (LMUP), which recognise the complexity of the construct, are being adopted worldwide. The aim of this study was to evaluate the psychometric properties of the Krio version of the LMUP in Sierra Leone. An interviewer-administered version of the LMUP was translated into Krio and pre-tested with 12 pregnant women. Field testing involved 172 pregnant women aged 15-42, with 87 completing a re-test. Completion rates of LMUP items were 100%. LMUP...
Source: African Journal of Reproductive Health - Category: African Health Tags: Afr J Reprod Health Source Type: research
Transmasculine people —those assigned female at birth and having a male or masculine gender identity—can experience unintended pregnancy, yet research on contraception among these individuals is scarce.
Source: The Guttmacher Institute - Category: International Medicine & Public Health Authors: Source Type: news
Publication date: Available online 1 April 2020Source: Preventive MedicineAuthor(s): R. Liam Sutherland, Jennifer Ormsbee, Joy Pader, Nauzer Forbes, Susanna Town, Robert J. Hilsden, Darren R. Brenner
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research
Condition:   Stroke, Ischemic Interventions:   Drug: Enteric Coated Aspirin Tablet;   Drug: Plain Aspirin Sponsor:   Hamad Medical Corporation Completed
Source: - Category: Research Source Type: clinical trials
Conditions:   Fetal Alcohol Spectrum Disorders;   Fetal Alcohol Syndrome;   Fetal Alcohol Effect Interventions:   Other: General information;   Behavioral: Baseline brief intervention;   Behavioral: Remote online booster sessions;   Behavioral: SMS Sponsors:   Wayne State University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Yale University;   Henry Ford Health System Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Inflammatory Bowel Disease;   Crohn Disease;   Ulcerative Colitis;   Vitamin D Deficiency Intervention:   Dietary Supplement: vitamin D3 Sponsor:   Boston Children’s Hospital Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Authors: Vesely MD Abstract Autoimmune diseases of the skin occur when the immune system attacks normal skin. The immune system can be broadly divided into an effector arm responsible for fighting infections and cancer and a regulatory arm that reduces autoreactivity and maintains immune homeostasis. Cutaneous autoimmunity develops when the equilibrium between the effector arm and regulatory arm of the immune system is disrupted. Recent insights into the inflammatory pathways that are overactive in some cutaneous autoimmune diseases have led to therapies targeting the effector arm of the immune system with greater ...
Source: The Yale Journal of Biology and Medicine - Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research
Authors: Wei BM, Hanlon D, Khalil D, Han P, Tatsuno K, Sobolev O, Edelson RL Abstract Dendritic cells (DCs) are professional antigen-presenting cells, necessary for the initiation and maintenance of antigen-specific immunity and tolerance. Decades of research have been driven by hopes to harness the immunological capabilities of DCs and achieve physiological partnership with the immune system for therapeutic ends. Potential applications for DC-based immunotherapy include treatments for cancer, autoimmune disorders, and infectious diseases. However, DCs have poor availability in peripheral and lymphoid tissues and h...
Source: The Yale Journal of Biology and Medicine - Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research
Authors: Little AJ, Vesely MD Abstract Cutaneous lupus erythematosus (CLE) is an autoimmune disease of the skin with significant morbidity. Current treatments are often inadequate to control disease and there are no Food and Drug Administration (FDA)-approved therapies for this potentially debilitating disease, underscoring an unmet medical need. Recent insights into disease pathogenesis have implicated innate and adaptive immune components, including type I and type III interferons in the development of CLE. Promising clinical trials based on these insights are now underway. However, the full spectrum of immune ce...
Source: The Yale Journal of Biology and Medicine - Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research
This study argues that a closer adherence to Med-Diet is independently associated with an increase of 25(OH)D suggesting that higher vitamin D levels may contribute to the protective effect of the Med-Diet on osteoporosis. PMID: 32223463 [PubMed - as supplied by publisher]
Source: International Journal of Food Sciences and Nutrition - Category: Nutrition Tags: Int J Food Sci Nutr Source Type: research
More News: Anemia | Antiphospholipid Syndrome | Aspirin | Autoimmune Disease | Cardiology | Coumadin | Heart | Heart Disease | Hughes Syndrome | Lupus | OBGYN | Pregnancy | Rheumatology | Thrombocytopenia | Thrombosis | Vitamin K | Vitamins | Warfarin